Actively Recruiting
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
Led by University Hospital, Montpellier · Updated on 2024-05-29
225
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will be the first to evaluate the role played by potential precipitating factors and risk factors in Reversible Cerebral Vasoconstriction Syndrome (RCVS) through of prospective selection of carefully characterised patients and controls. The impact of these factors on the prognosis will be evaluated through a follow-up assessment of patients. Our study will include the formation of a clinicoradiological database and a biobank (plasma, cerebro-spinal fluid, DNA) which will be the tools of a future large multicentre study on RCVS.
CONDITIONS
Official Title
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Patients treated at CHU of Montpellier
- Diagnosis of RCVS or RCVS without visible vasoconstriction within 14 days before inclusion
- Diagnosis based on consensual criteria and International Classification of Headache Disorders (ICHD-3)
- Provided written informed consent for study participation
- Control volunteers aged 18 years or older, matched by sex and age with patients
- Controls have acute non-neurological, non-vascular conditions or are healthy subjects
- Provided written informed consent for study participation
You will not qualify if you...
- Coma, insanity, language barriers, or severe aphasia preventing answering questions
- Follow-up considered impossible for 3 months (e.g., priority associated pathology or transfer)
- Individuals under legal protection
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gui de Chauliac Hospital
Montpellier, France, 34295
Actively Recruiting
Research Team
L
Lucas CORTI
CONTACT
A
Anne DUCROS, PU-PH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here